Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:parathyroid_hormone
|
| gptkbp:approvalYear |
2015
|
| gptkbp:ATCCode |
H05AA03
|
| gptkbp:blackBoxWarning |
risk of osteosarcoma
|
| gptkbp:CASNumber |
56603-78-6
|
| gptkbp:drugClass |
hormone replacement therapy
|
| gptkbp:form |
injection
|
| https://www.w3.org/2000/01/rdf-schema#label |
Natpara
|
| gptkbp:indication |
gptkb:hypoparathyroidism
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Takeda_Pharmaceuticals
|
| gptkbp:retired |
rubber particulates in vials
|
| gptkbp:routeOfAdministration |
subcutaneous injection
|
| gptkbp:UNII |
Q6T1Y44F1D
|
| gptkbp:withdrawalFromMarket |
2019
|
| gptkbp:bfsParent |
gptkb:Takeda
gptkb:Takeda_(Japan) |
| gptkbp:bfsLayer |
6
|